Petro River Oil, PTRC, Profile, Summary
Petro River Oil | PTRC | Profile | Summary
Petro is an emerging oil and gas producer focusing on assets in the Southeast Kansas region of the Mississippi Lime. Petro owns approximately 115,000 gross acres (85,000 net acres) with five producing oil and gas wells, in which Petro owns a 50% working interest and 40% net revenue interest.
Petro River’s activities are focused on its oil properties in the Mississippi Lime play in eastern Kansas. The Company has accumulated close to 100,000 acres with an extensive inventory of low cost drilling opportunities with potential for high returns. At current commodity prices, Mississippi Lime wells are averaging a 80% rate of return. Petro River Oil also has significant acreage and oil reserves in Missouri.
Source: Petro River, OxBridge Research, Daily Stock Deal, OTCking
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
Disclaimer/Disclosure: we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.
OxBridge Research initiates coverage of Teryl Resources,TRC.V, with a price target of 14 cents
Teryl Resources, TRC.V / TRYLF
OxBridge Research, a leading provider of investment research and investor relations services, today announced that it has initiated coverage of Teryl Resources with a price target of 14 cents.
Teryl Resources is a Junior Gold Mining company with assets in Fairbanks Mining District in Alaska and British Columbia. The Fairbanks Mining District is one of Alaska’s largest gold producing areas – gold production of over 40 million ounces.
The 31 page Report covers, Teryl's properties, its various Joint Venture partners including Kinross Gold Corporation (KGC) and Linux Gold Corp. (LNXGF) and future Gold market outlook.
The full Report is available for download for FREE at http://www.oxbridgeresearch.com/ and http://www.terylresources.com/ in addition to this Initiation Report, OxBridge Research will also provide ongoing coverage and event-based research updates on the Company.
Company Description
Teryl Resources Corp., TRC.V, is an early stage Canadian junior precious metals acquisition, exploration, and development company which holds interests in gold and silver properties in Alaska and British Columbia, Canada. Click here for complete Executive Summary
The Company is an accomplished explorer with a proven track record of exploration, development, and marketing its properties to mining majors. The Company has three properties in Alaska and one property in British Columbia. Teryl’s properties in Alaska are in the Fairbanks Mining District and include the West Ridge Property, Fish Creek Property, and Stepovich Property. Learn more about Teryl's strategy, see the Investment Highlights
The Fairbanks Mining District is one of the largest gold producing areas in Alaska. In 2011, Teryl sold its 20% stake in Gil Properties to Kinross Gold for US$15 million. see Teryl's Valuation
The Company’s single property in British Columbia is its Silverknife Property. Teryl also has oil and gas properties in Texas and Kentucky. To date, Teryl has spent over $2.2 million on exploration of its properties. Find out why the Analyst thinks the stock is undervalued, read Investment Thesis now
Sources: Teryl Resources Corp., Kinross Gold Corp., Linux Gold Corp., SilverCorp.
Forward-looking statements:-The Company's actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements, including those described in the Company's Financial Statements, Management Discussion and Analysis and Material Change Reports filed with the Canadian Securities Administrators and available at www.sedar.com, and the Company's 20-F annual report filed with the United States Securities and Exchange Commission at www.sec.gov.
This profile/research report/email letter/blog/posting in forums/social-media/t/f does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities of the Company have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Disclosure/Disclaimer:-OxBridge Research publishes sponsored research reports, advertorials and corporate profiles on its portal and several other websites/blogs, including this website/blog, owned and operated by OxBridge and/or its affiliates. OxBridge Research is not a Broker Dealer or a Registered Financial Adviser in any jurisdiction, whatsoever. All the information published on its website(s) and/or distributed to its members via various electronic means is for general awareness and entertainment purpose only. OxBridge urges investors to do their own due diligence and consult with their financial adviser prior to making any investment decision. We are expecting a payment of seven thousand dollars in compensation from the company/a third party/shareholder. We receive compensation from companies for providing various IR services, including consultation, publication, advertisement and social media awareness, therefore our views/opinion are inherently biased. Please read the full disclosure/disclaimer, if you need assistance contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it OxbridgeResearch.com, All Rights Reserved. Trademarks/logos are of their respective owners. It's YOUR money -Invest WISELY TM
GenVec, GNVC, Profile, Summary
GenVec | GNVC | Profile | Summary
GenVec, (GNVC) is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. A key component of the company's strategy is to develop and commercialize products through collaborations. GenVec is working with leading companies and organizations such as Novartis, Merial, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of a number of significant human and animal health concerns.
GenVec’s development programs address therapeutic areas such as hearing loss, balance disorders, and cancer; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), herpes simplex virus type 2 (HSV-2), dengue fever, influenza, malaria, and human immunodeficiency virus (HIV).
The GenVec's Advantage
The company's core technology has the important advantage of localizing protein delivery in the body. This is accomplished by using adenovector platform to locally deliver genes to cells, which then direct production of the desired protein. This approach reduces side effects typically associated with systemic delivery of proteins. For vaccines, the goal is to induce an immune response against a target protein or antigen. This is accomplished by using an adenovector to deliver a gene that causes production of an antigen, which then stimulates the desired immune reaction by the body.
GenVec’s novel proprietary adenovectors
?
No pre existing immune recognition
?
Built on rare human and nonhuman adenovirus serotypes
?
New GC technology shows superior performance for genetic vaccines
?
Multiple capsid modified vectors -AdH technology
?
Multiple genes/multiple antigens
?
Targeted and specific delivery Proprietary adenovectors and cell lines
?
Novel proprietary non replicating adenovirus vectors
•
Very low sero -prevalence in humans
•
Outstanding gene/antigen delivery properties
?
Cell line master banks and master file with FDA
Hearing Restoration Molecular Therapeutic
•
Dengue Virus Genetic Vaccine
•
Foot and Mouth Virus Genetic Vaccine
•
Malaria Genetic Vaccine
•
RSV Genetic Vaccine
•
HSV Molecular Therapeutic and Genetic Vaccine
A platform of adenovirus vectors built to meet product needs for molecular therapeutics and genetic vaccines
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks. OTCKing.com is an OxBridge affiliate/partner website.
Disclosure/Disclaimer:- OxBridge Research publishes sponsored research reports, advertorials and corporate profiles on its portal and several other websites/blogs, including this website/blog, owned and operated by OxBridge and/or its affiliates. OxBridge Research is not a Broker Dealer or a Registered Financial Adviser in any jurisdiction, whatsoever. All the information published on its website(s) and/or distributed to its members via various electronic means is for general awareness and entertainment purpose only. OxBridge urges investors to do their own due diligence and consult with their financial adviser prior to making any investment decision. We are expecting a payment from the company/a third party/shareholder. We receive compensation from companies for providing various IR services, including publication, advertisement,and social media awareness, therefore our views/opinion are inherently biased. Please read the full disclosure/disclaimer, if you need assistance contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it
OxbridgeResearch.com, All Rights Reserved. Trademarks/logos are of their respective owners.
It's YOUR money - Invest WISELY TM
Teryl Resources, TRC.V/TRYLF, Profile
Teryl Resources | TRC.V/TRYLF | Profile
Teryl Resources Corp., - TRC.V / TRYLF – has several gold prospects near the Kinross Gold Corp's Fort Knox Mine in Alaska, a silver/lead/zinc prospect adjacent to Silvercorp's (SVM) mine in British Columbia, and Oil & Gas wells in Texas.
Teryl has a 10% net profit interest in the Stepovich claims. A 100% interest in the Westridge property and a 50% interest in the Fish Creek property, adjacent to the Gil property. Teryl sold its 20% interest in the Gil property in Fairbanks, Alaska, to Fairbanks Gold Mining Corp., a wholly owned subsidiary of Kinross Gold Corp. (KCG), for $15 million dollars plus a ½ of 1% royalty for the life of the mine.
Teryl owns a 30% working interest and a 10% NPI interest in the Silverknife property, a silver/lead/zinc prospect located in Northern B.C. adjacent to Silvercorp's silver/lead/zinc discovery.
Teryl also has three producing oil and gas wells in Texas, these wells are operated by Anadarko Petroleum.
Fish Creek property
Teryl Resources has commenced a placer and hard rock diamond drilling program on the Fish Creek property in the Fairbanks, Alaska mining district.
Teryl's consulting geologist, Paul D. Gray, P.Geo. will oversee the drilling program, core logging , and assay protocols on behalf of the Company. The operator of the drill will be Kenn Roberts of Texas, and Pete Rutledge, project manager.
Kenn Roberts, a First Nations from Yukon has multiple years of drilling experience in remote locations and has served as mineral development advisor to First Nations.
Teryl owns a 50% interest in the Fish Creek property, Keltic Bryce owns a 50% working interest and Linux Gold Corp. (LNXGF) retains a 5% royalty interest in Teryl's interest.
The Fish Creek property consists of 30 claims adjacent to the Gil property, currently owned by Kinross Gold Corporation. The Gil 20% interest, previously owned by Teryl Resources Corp., was acquired by Kinross for $15 million dollars.
Westridge Property
A geological report on the Westridge gold property has been prepared by David Adams, B.S., M.S., CPG. Teryl has appointed Pete Rutledge, Geologist, as an independent contractor to evaluate the Westridge property.
The Westridge property is located approximately 16 km north of Fairbanks, Alaska. The property consists of 48 State of Alaska mining claims controlled by Teryl Resources Corp.
The claims cover approximately 1,749 acres on the north flank of the main ridge between Pedro Creek and upper Dome Creek; both of these drainages were significant historic placer gold producers. Access to the property is excellent: the Elliott Highway transects the westernmost edge of the property, and the Silver Fox Mine road transects the southwest portion of the property.
All claim holdings comprising the property are in good standing, and no encumbrances to future mining activities are known or anticipated.
SILVERKNIFE PROPERTY OWNERSHIP:
» Teryl Resources Corp. owns 30% working
interest and has a 10% Net Profit Interest
(“NPI”)
» Minewest Silver & Gold owns 70% subject to
the 10% NPI held by Teryl
The Silverknife Property
(Mineral Claims consisting of 1,594 Acres)
A proposed Phase I exploration program consisting of a desk study followed by a series of on-the-ground Property boundary and drill collar location surveys, followed by geophysics and diamond drilling with a
recommended budget of $358,700 is recommended for the Silverknife Property.
The exploration programs (and budgets), presented herein, are designed to identify the accurate location of the mineral titles
boundary with respect to historic drill collars and test the Silverknife Property’s precious and base metal mineral potential and will yield enough information to guide Minewest and Teryl subsequent mineral
exploration programs on the Property. Samples have been collected to confirm the assay results, however, due to the inclement weather conditions, the Phase I exploration program has been delayed.
Sources: Teryl Resources Corp., Kinross Gold Corp., Linux Gold Corp., SilverCorp.
Forward-looking statements:- The Company's actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements, including those described in the Company's Financial Statements, Management Discussion and Analysis and Material Change Reports filed with the Canadian Securities Administrators and available at www.sedar.com, and the Company's 20-F annual report filed with the United States Securities and Exchange Commission at www.sec.gov.
This profile/research report/email letter/blog/posting in forums/social-media/t/f does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities of the Company have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Disclosure/Disclaimer:- OxBridge Research publishes sponsored research reports, advertorials and corporate profiles on its portal and several other websites/blogs, including this website/blog, owned and operated by OxBridge and/or its affiliates. OxBridge Research is not a Broker Dealer or a Registered Financial Adviser in any jurisdiction, whatsoever. All the information published on its website(s) and/or distributed to its members via various electronic means is for general awareness and entertainment purpose only. OxBridge urges investors to do their own due diligence and consult with their financial adviser prior to making any investment decision. We are expecting a payment of up to five thousand dollars in compensation from the company/a third party/shareholder. We receive compensation from companies for providing various IR services, including publication, advertisement,and social media awareness, therefore our views/opinion are inherently biased. Please read the full disclosure/disclaimer, if you need assistance contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it
OxbridgeResearch.com, All Rights Reserved. Trademarks/logos are of their respective owners.
It's YOUR money - Invest WISELY TM
Feed Entries
